Michael Henry
@brainplast
Followers
384
Following
9K
Media
137
Statuses
2K
Husband. Father. Research Scientist. In a journey to grasp the spirit - mind - body connection. Caring for the whole man.
Lagos-Durban-Calgary
Joined February 2019
New mental health funding open for applications! We’re supporting teams to accelerate the evaluation and roll out of social and psychological interventions for anxiety, depression and psychosis in young people. Wellcome’s Kim Donoghue explains more ⤵️ https://t.co/LBe5ATjP0J
0
13
21
Meet the grads, Spring 2025: Henry Ukachukwu Michael, PhD, Experimental Medicine. @mcgill_DOM Congratulations Henry! Read more: https://t.co/K1gVDnWwoM
0
2
5
TRAINEE SPOTLIGHT Pegah Noorshargh is a first-year MSc student in Biostatistics. Her graduate research focuses on developing novel machine-learning algorithms to examine heterogeneity in how patients with heart disease respond to & interpret questions about their health status.
1
2
4
Join @drandyclegg in our next seminar for a discussion of their work developing the second version of the Electronic Frailty Index, used to identify frailty in older people 🗓️ Monday 31 March 🕰️ 12:45 (UK time) 📍 LSHTM | Online More details ⬇️ https://t.co/dhc0AEgTXN
0
5
6
Interested in building a foundation of #causalinference methodology? Key Topics in Causal Inference (KTCI) is designed for researchers interested in acquiring a roadmap to navigate the causal research landscape. 📆 June 16-20, 2025 Register for KTCI: https://t.co/pElPB1M13u
3
4
15
The ISPE Student Council is proud to present the 2025 RWE Research Proposal Competition. 📷 Registration is now open! 📷The winning team will get the opportunity to present their proposal at a SISPE Webinar! Learn more at the link and register today! https://t.co/RTSTAfeAGz
0
1
2
Are you interested in participating for the 2025 Research Proposal Competition but unsure how to proceed? Please fill out this quick survey so that we can assist you with your questions! https://t.co/kVwCzVft3p
docs.google.com
0
3
5
Catch up on Sleepwell’s 2ndnational webinar "Worrying About Sleep? That May Be Part of the Problem" featuring guest speaker and sleep expert Dr. Malgorzata Rajda! Watch the recording to learn about insomnia, CBT-i, the impact of worry on sleep, and more:
0
2
4
“Sleeping pills can't undo the causes of chronic insomnia” Hear Sleepwell co-founder & CADeN exec member Dr. David Gardner speak about sleeping pills, CBT-i techniques & how they can help treat causes of chronic insomnia in @CBCRadioCanada's The Current: https://t.co/eGyBx5FYjO
0
3
9
Upgrade your #causalinference arsenal. A revision of our book "Causal Inference: What If" is available at https://t.co/3rrh0l8nFu Thanks to everyone who suggested improvements, reported typos, and proposed new citations and material. Enjoy the #WhatIfBook. Also, it's free.
15
249
902
Hear CADeN director @DrEmilyMcD speak about the GABA-WHY study, which found the EMPOWER brochures to be low-cost tools to promote patient-directed #deprescribing of gabapentinoids: https://t.co/SKwxusDbwS
jamanetwork.com
This study examines gabapentinoid deprescribing using a novel approach of direct-to-consumer educational brochures intended to empower older adults to initiate a discussion on gabapentinoid risks and...
#Deprescribing Super Special III: We explore 4 studies highlighting innovative approaches to #ReducingMedication use and improving patient outcomes. Guests @ConstanceFungMD, @DrEmilyMcD, @amy_linsky, & Michelle Odden. Ep. https://t.co/JfE9DBrlat - hosts @AlexSmithMD | @EWidera
0
2
4
Learn to use structural equation modeling (SEM) to estimate dynamic panel data models w/ Paul Allison. Longitudinal Data Analysis Using SEM begins Feb. 24. This 4-week on-demand seminar introduces maximum likelihood with SEM software (ML-SEM) using Mplus, Stata, SAS, and R.
0
4
30
Le Club de lecture international sur la déprescription est de retour ! Dre Anne Marie Pinard, anesthésiste et membre du Réseau québécois de recherche sur la douleur présentera sur la déprescription dans le context de la douleur chronique. @rqrd_qprn Dre Pinard décrira le
0
3
5
Study in nursing homes across the Netherlands 🇳🇱: Only half of psychotropic drug use cases met guideline recommendations for appropriateness: https://t.co/TGX5QsHUCB
@JAMDAcom
@NDeprescribing More work needs to done to reduce this discrepancy. https://t.co/sx1AFeDwZd
0
4
9
We are thrilled to welcome Dr. Henry Michael (@brainplast) to our research group as a postdoctoral associate! Before joining us, he earned his PhD in Experimental Medicine from McGill University, where he explored the intersection of medication burden, frailty, and....
1
4
7
Calling caregivers & people supporting older adults! Don’t miss this Wednesday’s FREE webinar to learn how medications affect us differently as we age, and how to minimize medication harms. This session is hosted by CORE Alberta and presented by Dr. Lisa Tate, clinical
0
2
2
CADeN Research Committee member @brainplast was interviewed by @physicianswkly to discuss his recent study, highlighting the negative impacts of anticholinergics and sedatives on cognition & frailty in older adults with HIV! Findings also shed light on the importance of mental
0
1
7
More data to suggest using low-dose quetiapine for insomnia in older adults can be associated with higher rates of mortality, dementia, and falls: https://t.co/RMkdNvzNau Learn more about #deprescribing potentially inappropriate #antipsychotics here: https://t.co/ELGDbrJGOM
2
20
46
Proud to be co-chairing this pan-Canadian coalition with @ChooseWiselyCA’s Wendy Levinson. I believe the work will be impactful for Canadians and for the better use of medicine.
CADeN is proud to unite along with 10 organizations to form the Appropriate Use Coalition, a grassroots group committed to improving patient outcomes and reducing risks through appropriate prescribing. Learn more: https://t.co/sm89tfK5p7
1
3
18
Key Takeaways from “Regression Modeling Strategies” by Frank Harrell (@f2harrell) A must-read for anyone working with predictive modeling. Here’s what you need to know: Plan your model with clear goals—whether prediction, effect estimation, or hypothesis testing. Avoid
11
120
632